Aishwarya Sriraman
Overview
Explore the profile of Aishwarya Sriraman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flores-Fernandez J, Pesch V, Sriraman A, Chimal-Juarez E, Amidian S, Wang X, et al.
Bioeng Transl Med
. 2024 Jul;
9(4):e10665.
PMID: 39036077
Synucleinopathies, including Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB), are neurodegenerative disorders caused by the accumulation of misfolded alpha-synuclein protein. Developing effective vaccines against...
2.
Clay W, Buck A, He Y, Hernandez Sanchez D, Ward N, Lear J, et al.
Chem Res Toxicol
. 2024 Apr;
37(4):643-657.
PMID: 38556765
Organophosphorus (OP) nerve agents inhibit acetylcholinesterase (AChE), creating a cholinergic crisis in which death can occur. The phosphylated serine residue spontaneously dealkylates to the OP-aged form, which current therapeutics cannot...
3.
Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson's disease
Pesch V, Flores-Fernandez J, Reithofer S, Ma L, Ozduzenciler P, Busch Y, et al.
Brain
. 2024 Mar;
147(5):1644-1652.
PMID: 38428032
The pathological misfolding and aggregation of soluble α-synuclein into toxic oligomers and insoluble amyloid fibrils causes Parkinson's disease, a progressive age-related neurodegenerative disease for which there is no cure. HET-s...
4.
Cortez L, Nemani S, Duque Velasquez C, Sriraman A, Wang Y, Wille H, et al.
PLoS Pathog
. 2021 Jun;
17(6):e1009703.
PMID: 34181702
Prion diseases are transmissible neurodegenerative disorders that affect mammals, including humans. The central molecular event is the conversion of cellular prion glycoprotein, PrPC, into a plethora of assemblies, PrPSc, associated...
5.
Madhavan S, Sriraman A, Freels S
Brain Sci
. 2016 Jul;
6(3).
PMID: 27472368
Background: Transcranial direct current stimulation (tDCS) is emerging as a promising adjuvant to enhance motor function. However, there has been increasing reservations about the reliability and variability of the neuromodulatory...
6.
Sriraman A, Oishi T, Madhavan S
Brain Res
. 2014 Jul;
1581:23-9.
PMID: 25063361
Transcranial direct current stimulation (tDCS) has gained increasing interest in neurorehabilitation with its ability to modulate cortical excitability, and thereby influence neural plasticity and functional recovery. While the beneficial effects...